SCHEMBL4968971

SCHEMBL4968971

Cc1ccc2c(N(C(=O)O)C3CCNC3)nc(-c3ccccc3O)nc2c1

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 19/20 0.62
CHEK1 O14757 10/20 0.45
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5505763 1.00 CHEK2 (0.62) CHEK2CHEK1KMT2A
SCHEMBL6111032 1.00 CHEK2 (0.62) CHEK2CHEK1KMT2A
Hydrochloric Acid SCHEMBL4969202 0.99 CHEK2 (0.61) CHEK2CHEK1KMT2A
SCHEMBL5503310 0.95 CHEK2 (0.55) CHEK2CHEK1KMT2A
SCHEMBL5500532 0.95 CHEK2 (0.55) CHEK2CHEK1KMT2A
SCHEMBL5500526 0.95 CHEK2 (0.55) CHEK2CHEK1KMT2A
SCHEMBL5507443 0.94 CHEK2 (0.56) CHEK2CHEK1KMT2A
SCHEMBL4969100 0.88 CHEK2 (0.54) CHEK2CHEK1KMT2A
SCHEMBL4969097 0.88 CHEK2 (0.54) CHEK2CHEK1KMT2A
SCHEMBL4970389 0.88 CHEK2 (0.47) CHEK2CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957482-A2 QUINAZOLINES USEFUL AS MODULATORS OF VOLTAGE GATED ION CHANNELS Vertex Pharmaceuticals, Inc. (US) 2008-08-20 EP disclosed
WO-2007058989-A2 QUINAZOLINES USEFUL AS MODULATORS OF VOLTAGE GATED ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-05-24 WO disclosed
EP-1784393-A1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2007-05-16 EP disclosed
WO-2006028904-A9 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2006-06-22 WO disclosed
WO-2006028904-A1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-03-16 WO disclosed